CLOSED
The SPORE program was initiated by the National Cancer Institute to promote interactions between basic and applied investigators as well as to provide them with the flexibility to rapidly evaluate new approaches for the prevention, early detection, diagnosis, and treatment of human cancer.
Each SPORE allocates significant effort to two distinct funding programs, the Developmental Research Program and the Career Enhancement Program:
Goal: The Developmental Research Program supports pilot projects focusing on innovative and interdisciplinary translational research. High risk/High impact projects that take advantage of new research opportunities in the prostate cancer research field and promote multidisciplinary collaboration between basic, preclinical and clinical programs are particularly encouraged.
Eligibility: Developmental Research Program Awards are available for faculty members associated with UCLA , the Cedars-Sinai Medical Center, or the City of Hope to support innovative translational research in all areas of investigation that impact prostate cancer.
Award: One-year awards of up to $50,000 (direct costs) will be awarded as of June 1, 2019.
Funds can be used for technical support or supplies. Principal investigator salaries or purchase of equipment are not allowable. Applications will not be funded until approval is obtained from the appropriate committees overseeing animals, radiation, human subjects, and hazardous materials. Semi-annual and end-of-project reports are required. Carryforward of funds is not allowed. A second year of funding may be requested as appropriate if substantial progress has been demonstrated.
Review criteria include the 1) scientific merit, 2) translational potential, 3) relevance to prostate cancer, 4) potential for collaborative research, 5) qualifications of the investigative team to perform the proposed research, 6) identification of proposed resources and, 7) potential for independent research in prostate cancer.
Submission Deadline: Monday, April 1, 2019; 5pm PDT
How to apply: Please attach all required components to the completed PDF application template and submit as one single PDF online at: http://spore.ctrl.ucla.edu/seedgrants
The application components are listed in the proposal template (PDF) >
RFA questions: SPORE Administrative Coordinator; sporeinfo@dgsom.ucla.edu
Technical Support for online application: rfp-support@ctrl.ucla.edu
Goal: The Career Enhancement Program supports junior faculty and established researchers who wish to commit their research interests to or refocus on translational approaches in the prostate cancer research area.
Eligibility: Career Enhancement Program Awards are available for M.D. or Ph.D. junior faculty and senior faculty associated with UCLA, the Cedars-Sinai Medical Center, or the City of Hope. Exceptional postdoctoral fellows with plans to transition to a faculty position within a year may also apply, but must submit a letter from an institution supporting their transition to faculty.
Award: One-year awards of up to $50,000 (direct costs) will be awarded as of June 1, 2019.
Funds can be used to support research activities including partial salary support for the candidate, research personnel, supplies, travel, and other expenses. Applications will not be funded until approval is obtained from the appropriate committees overseeing animals, radiation, human subjects, and hazardous materials. Semi-annual and end-of-project reports are required. Carryforward of funds is not allowed. A second year of funding may be requested as appropriate if substantial progress has been demonstrated.
Review criteria include the 1) quality of the scientific proposal, 2) the candidate's potential for an independent prostate cancer research career, 3) potential impact of the research on the field of prostate cancer, 4) relevance to the overall translational research mission of the prostate cancer SPORE program, 5) commitment of the mentor, and 6) personal career development plan.
Submission Deadline: Monday, April 1, 2019; 5pm PDT
How to apply: Please attach all required components to the completed PDF application template and submit as one single PDF online at: http://spore.ctrl.ucla.edu/seedgrants
The application components are listed in the proposal template (PDF) >
RFA questions: SPORE Administrative Coordinator; sporeinfo@dgsom.ucla.edu
Technical Support for online application: rfp-support@ctrl.ucla.edu
Read more about previously funded projects of the Developmental Research Program and the Career Enhancement Program.
CLOSED
UCLA SPORE in Prostate Cancer (Specialized Programs of Research Excellence)
Request for Proposals for Major Research Projects (For possible inclusion in our 09/2017 competing renewal application)
Due: March 24, 2017
The UCLA SPORE in Prostate Cancer announces a request for proposals for prostate cancer research projects (for up to a 5-year period). This RFP details our criteria for selecting projects for inclusion in the competitive renewal application (September 22, 2017). The SPORE Funding Opportunity Announcement (FOA) should be reviewed and considered when designing the overall scope and direction of projects, and the NIH Program Announcement (PAR-14-353) can be found here: http://grants.nih.gov/grants/guide/pa-files/PAR-14-353.html.
The proposals will be evaluated on the appropriateness of the science and the other key SPORE requirements as well as the compatibility with the existing goals of the UCLA SPORE in Prostate Cancer. Information about the existing projects of our SPORE can be found at: http://urology.ucla.edu/project-cores.
Priority Research Areas
This program is most interested in soliciting applications from scientists and clinical investigators with experience or interest in developing new approaches to prevention and treatment of prostate cancer. Each project must consist of one clinical investigator and one basic scientist.
Examples of potential projects may involve, but are not limited to:
The highest priority for inclusion in the competitive renewal application will be given to
translational research projects demonstrating collaboration between clinicians and research scientists. For the SPORE Program, the NCI defines translational research as follows: “Translational research uses knowledge of human biology to develop and test the feasibility of cancer-relevant interventions in humans and/or determines the biological basis for observations made in individuals with cancer or in populations at risk for cancer.” The term “Interventions” is used in its broadest sense to include molecular assays, imaging techniques, drugs, biological agents, and/or other methodologies applicable to the prevention, early detection, diagnosis, prognosis, and/or treatment of cancer. SPORE translational research projects may involve the use of any cellular, molecular, structural, biochemical, and/or genetic experimental approaches.
The criteria for judging these applications will be: 1) scientific merit, 2) highly translational and must always be focused upon knowledge of human biology stemming from research using cellular, molecular, structural, biochemical, and/or genetic experimental approaches with the goal of a translational human endpoint* within the project period of the grant, 3) relevance to prostate cancer, 4) potential for collaborative research, 5) qualifications of the investigative team to perform the proposed research, 6) identification of proposed resources, and 7) must possess a large amount of preliminary data.
* At least one of the following types of human endpoints should be proposed in each SPORE research project:
Application is limited to UCLA, Cedars-Sinai Medical Center, or City of Hope faculty with a distinguished funding history who have a strong, demonstrable research base in the field of prostate cancer.
APPLICATION PROCESS: Faculty considering submitting an application MUST first contact Drs. Robert Reiter and Owen Witte by email at rreiter@mednet.ucla.edu and owenwitte@mednet.ucla.edu. The application does not need a goldenrod and does not go through the Office of Contracts and Grants. There are no specific forms. The first page should contain the name of the principal investigators with complete mailing address including campus mail code, phone and fax numbers and e-mail address and a half-page abstract that clearly states the hypothesis, its importance to prostate cancer, the specific aims of the project, and the proposed experimental approach. Background, Preliminary Data, Proposed Experiments, any other Text, Figures and References may not exceed 5 pages (11 pt font). If essential, attach no more than one relevant reprint or preprint. NIH-style Biosketches and Other Support Pages must accompany the application. The application documents should be submitted as one single PDF file. An application must be submitted by March 24, 2017 on the UCLA SPORE website at http://spore.ctrl.ucla.edu/renewal.
Pre-proposals are due in the SPORE office on March 24, 2017 (submitted online at http://spore.ctrl.ucla.edu/renewal). The Prostate SPORE PIs will review the applications and select several potential projects for presentation by the applicant at the External Advisory Board meeting on May 8, 2017. The Executive Committee will approve the final projects for inclusion in the renewal application. A formal notice will then be issued to successful applicants outlining the terms and requirements for submitting a complete proposal and budget within the timeline of the SPORE’s competing renewal application cycle. In the interest of building collaborative opportunities - a primary goal of the SPORE mechanism - both the project leader and co-leader are expected to participate in as many of the SPORE-related meetings and seminars as possible.
For questions, please contact Sarah Connor, UCLA Urology Research Manager, and Linn Dahlman, UCLA SPORE Administrator, via email at sporeinfo@dgsom.ucla.edu or by phone at 310-794-2481.
CLOSED
Read more about previously funded projects of the Developmental Research Program and the Career Enhancement Program.
The SPORE program was initiated by the National Cancer Institute to promote interactions between basic and applied investigators as well as to provide them with the flexibility to rapidly evaluate new approaches for the prevention, early detection, diagnosis, and treatment of human cancer.
Each SPORE allocates significant effort to two distinct funding programs, the Developmental Research Program and the Career Enhancement Program:
Goal: The Developmental Research Program supports pilot projects focusing on innovative and interdisciplinary translational research. High risk/High impact projects that take advantage of new research opportunities in the prostate cancer research field and promote multidisciplinary collaboration between basic, preclinical and clinical programs are particularly encouraged.
Eligibility: Developmental Research Program Awards are available for faculty members associated with UCLA , the Cedars-Sinai Medical Center, or the City of Hope to support innovative translational research in all areas of investigation that impact prostate cancer.
Award: One-year awards of up to $50,000 (direct costs) will be awarded as of September 01, 2016.
Funds can be used for technical support or supplies. Principal investigator salaries or purchase of equipment are not allowable. Applications will not be funded until approval is obtained from the appropriate committees overseeing animals, radiation, human subjects, and hazardous materials. Semi-annual and end-of-project reports are required. Carryforward of funds is not allowed. A second year of funding may be requested as appropriate if substantial progress has been demonstrated.
Review criteria include the 1) scientific merit, 2) translational potential, 3) relevance to prostate cancer, 4) potential for collaborative research, 5) qualifications of the investigative team to perform the proposed research, 6) identification of proposed resources and, 7) potential for independent research in prostate cancer.
How to Apply: The application components are listed in the proposal template (PDF) >
CLOSED
Submission Deadline: Monday, July 18, 2016; 5pm PDT
Goal: The Career Enhancement Program supports junior faculty and established researchers who wish to commit their research interests to or refocus on translational approaches in the prostate cancer research area.
Eligibility: Career Enhancement Program Awards are available for M.D. or Ph.D. junior faculty and senior faculty associated with UCLA, the Cedars-Sinai Medical Center, or the City of Hope. Exceptional postdoctoral fellows with plans to transition to a faculty position within a year may also apply, but must submit a letter from an institution supporting their transition to faculty.
Award: One-year awards of up to $50,000 (direct costs) will be awarded as of September 01, 2016.
Funds can be used to support research activities including partial salary support for the candidate, research personnel, supplies, travel, and other expenses. Applications will not be funded until approval is obtained from the appropriate committees overseeing animals, radiation, human subjects, and hazardous materials. Semi-annual and end-of-project reports are required. Carryforward of funds is not allowed. A second year of funding may be requested as appropriate if substantial progress has been demonstrated.
Review criteria include the 1) quality of the scientific proposal, 2) the candidate's potential for an independent prostate cancer research career, 3) potential impact of the research on the field of prostate cancer, 4) relevance to the overall translational research mission of the prostate cancer SPORE program, 5) commitment of the mentor, and 6) personal career development plan.
How to Apply: The application components are listed in the proposal template (PDF) >
CLOSED
Submission Deadline: Monday, July 18, 2016; 5pm PDT
RFA questions: SPORE Administrative Coordinator; sporeinfo@dgsom.ucla.edu
Technical Support for online application: Maryam Ariannejad, marian@mednet.ucla.edu
